Resources

Polls

: Should patients and care partners be more involved in clinical trial design ?

Yes

No

Unsure

Astellas Statement on 21st Century Cures Act

Dec 7, 2016

Astellas applauds Congress’ passage of the 21st Century Cures Act. We believe the final legislative package is a very positive step toward a common goal of efficiently bringing safe and effective new medicines to patients whose medical needs are not met by currently available therapies.

We are particularly heartened by the legislation’s investment in basic research, dedicated resources to help the Food and Drug Administration keep pace with our sector’s rapidly-advancing science, and efforts to prioritize the patient experience in drug development and review. Astellas looks forward to working with policymakers and regulators on the implementation of 21st Century Cures.

Astellas Patient Advocacy is a function within Corporate Affairs at Astellas that focuses on creating, building and maintaining third-party relationships. We serve as a conduit between Astellas and external stakeholders to help improve patient outcomes, improve access issues and address patients’ unmet needs head on.